ReviewHealth science reports2025
The Use of Diagnostic Tumor Markers in Detecting Tobacco- and Betel Quid-Induced Oral Squamous Cell Carcinoma: A Scoping Review of Empirical Evidence.
Review in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Tobacco and betel quid are two major causes of oral squamous cell carcinoma (OSCC). Tumor biomarkers offer potential headway for improved diagnosis of OSCC caused by tobacco and betel quid. Currently, several empirical investigations have explored the use of diverse types of tumor biomarkers in the diagnosis of tobacco- and betel quid-induced OSCC; however, no known study has mapped the evidence reported in those studies. This scoping review aims to map existing empirical evidence on the biomarkers of OSCC caused by these carcinogenic substances. Methods: This scoping review adhered to the PRISMA-ScR checklist. Seven databases (PubMed, SCOPUS, AMED, APA PsycArticles, APA PsycINFO, CINAHL Ultimate, Dentistry, and Oral Sciences Source) were searched to retrieve literature on diagnostic tumor markers used in detecting tobacco- and betel quid-induced OSCC. After deduplication and screening of research articles based on the eligibility criteria. Only 36 peer-reviewed articles met the inclusion criteria of the scoping review. Data from the selected articles were charted, collated, summarized, and presented. Results: All the included articles were on studies published within the past decade. Most of them (26 articles) reported case-control studies. More than half (20 articles) were on studies conducted in India. A total of 6707 participants were investigated in the included articles, and different oral anatomical sites were involved. The biomarkers investigated were of diverse types, ranging from genomic biomarkers to transcriptomic markers. Specifically, these markers include micronuclei, miRNAs, protein markers, gene alterations, and salivary markers. These biomarkers were used in the early detection, risk assessment, and prognosis evaluation of tobacco-/betel quid-induced OSCC. Conclusion: This scoping review provides insights into the current global research landscape on the use of biomarkers in the diagnosis of tobacco- and betel quid-induced OSCC; it also provides potential avenues for improving early detection and management of this prevalent oral malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.